XORTX Therapeutics Shares Outstanding vs. Shares Owned By Insiders
| XRTX Stock | 1.75 0.01 0.57% |
For XORTX Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of XORTX Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well XORTX Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between XORTX Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of XORTX Therapeutics over time as well as its relative position and ranking within its peers.
XORTX |
XORTX Therapeutics Shares Owned By Insiders vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining XORTX Therapeutics's current stock value. Our valuation model uses many indicators to compare XORTX Therapeutics value to that of its competitors to determine the firm's financial worth. XORTX Therapeutics is rated second in shares outstanding category among its peers. It is rated second in shares owned by insiders category among its peers . The ratio of Shares Outstanding to Shares Owned By Insiders for XORTX Therapeutics is about 1,070,950 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the XORTX Therapeutics' earnings, one of the primary drivers of an investment's value.XORTX Shares Owned By Insiders vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
XORTX Therapeutics |
| = | 3.22 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
XORTX Therapeutics |
| = | 3.01 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
XORTX Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in XORTX Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, XORTX Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of XORTX Therapeutics' change in net profit over the period of time. It can combine multiple indicators of XORTX Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Loss | -8.5 M | -8.1 M | |
| Net Interest Income | 253.5 K | 266.2 K | |
| Operating Income | -6 M | -5.7 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Income Before Tax | -2.2 M | -2.3 M | |
| Total Other Income Expense Net | 3.6 M | 3.8 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Interest Income | 255.2 K | 196.1 K | |
| Change To Netincome | -4.1 M | -3.9 M | |
| Net Loss | (1.44) | (1.52) | |
| Income Quality | 2.26 | 2.37 |
XORTX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on XORTX Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of XORTX Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the XORTX Therapeutics' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in XORTX Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Use Investing Themes to Complement your XORTX Therapeutics position
In addition to having XORTX Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Restaraunts Hotels Motels Thematic Idea Now
Restaraunts Hotels Motels
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Restaraunts Hotels Motels theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Restaraunts Hotels Motels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.